pindolol has been researched along with Mitral Valve Insufficiency in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schumacher, C | 1 |
| Becker, H | 1 |
| Conrads, R | 1 |
| Schotten, U | 1 |
| Pott, S | 1 |
| Kellinghaus, M | 1 |
| Sigmund, M | 1 |
| Schöndube, F | 1 |
| Preusse, C | 1 |
| Schulte, HD | 1 |
1 other study available for pindolol and Mitral Valve Insufficiency
| Article | Year |
|---|---|
Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
Topics: Adult; Cardiomyopathy, Hypertrophic; Catecholamines; Cell Membrane; Female; Humans; In Vitro Techniq | 1995 |